Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 12/27/2025Telix Advances Regulatory Efforts with Positive China Phase 3 Data
  • 12/27/2025CDE Seeks Comments on Chinese Translation of ICH M8 eCTD Guidelines
  • 12/27/2025NMPA Announces Adoption of ICH E6(R3) Guidelines for Clinical Trial Qu...
  • 12/27/2025Hemacell Completes Series B1 Financing to Advance Platelet Regeneratio...
  • 12/27/2025Chengdu Maxvax Biotech Completes D+ Financing Round
  • 12/27/2025China Approves Novo Nordisk's Sogroya for Pediatric Growth Hormone Def...
  • 12/27/2025LyncBio Therapeutics Completes Strategic Pre-A Financing Round
  • 12/27/2025Zai Lab's COBENFY Approve in China for Schizophrenia
  • 12/27/2025Frontera's HKSE IPO Application Accepted
  • 12/27/2025GRIT's Next-Generation Gene-Edited TIL GT307 Receives FDA IND Approval
  • 12/27/2025Guangzhou Novaken Pharm Files for HKSE Main Board Listing
  • 12/27/2025NMPA Approves Amgen/UCB's Evenity for Postmenopausal Osteoporosis
  • 12/27/2025Novo Nordisk's Wegovy Approved in China for Cardiovascular Risk Reduct...
  • 12/27/2025China Approves GSK's Nucala for Maintenance Treatment of Eosinophilic ...
  • 12/27/2025Coherent Licenses CBP-1018 to MultiValent Biotherapies in Major Global...
  • 12/23/2025Aurobindo Pharma to Increase Stake in Chinese JV Luoxin Aurovitas
  • 12/23/2025CSPC Announces China Approval for Daratumumab Injection
  • 12/23/2025Grand Secures China Rights to World's First Adrenaline Nasal Spray fr...
  • 12/23/2025Qilu Launches Phase 1 Trial of FIC CD3/CD20/CD79b Triple Antibody QLS2...
  • 12/23/2025Ipsen Expands Oncology Pipeline with Global Licensing of Simcere Zaimi...
  • 12/23/2025T-MAXIMUM Secures FDA Approval to Advance Off-the-Shelf CAR-T Therapy
  • 12/23/2025PepBio Raises Series A Financing to Advance AI-Driven Peptide Drug Pip...
  • 12/23/2025China Approves First Global CSF-1R Inhibitor Pimicotinib for Rare Join...
  • 12/22/2025NMPA Announces Revision of Montelukast Product Labels to Strengthen Dr...
  • 12/22/2025Windward Bio Licenses Long-Acting TSLP/IL-13 Bispecific WIN027 from Qy...
  • 12/22/2025Zelgen Files for Hong Kong IPO, Showcasing Commercial Portfolio and Mu...
  • 12/22/2025AstraZeneca Strengthens KRAS Oncology Strategy with Pan-KRAS Deal from...
  • 12/22/2025Alphamab's IND for PD-L1/VEGFR2 Bispecific ADC JSKN027 Accepted in Chi...
  • 12/22/2025Rezubio Raises $20M Series A to Advance Membrane-Anchored Therapeutics...
  • 12/22/2025Epigenic Wins FDA IND Clearance for Novel Epigenetic Therapy Targeting...
  • Page:1/59 Total number of articles:1742: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group